MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-29-0028271
Incorporeal Pharma Private Limited
Incorporeal Pharma Private Limited - trading in Sangli, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹98.2 Lakh
▲ 9% YoY
Net profit · FY 2025
₹38,363
Net margin 0.4%
EBITDA · FY 2025
₹46,728
EBITDA margin 0.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
6
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Incorporeal Pharma Private Limited
Data last updated:
Incorporeal Pharma Private Limited is a private limited company based in Sangli, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 22 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2021PTC205424.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sachin Bhagwant Gondhale and Aniket Sangameshwarkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G3 Pranam Arcade Kacchi Bhavan Sangli, Maharashtra, India – 416416.
As per the financials filed for FY 2025, the company reported a revenue of ₹98.2 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹38,363 (net margin 0.4%) and EBITDA of ₹46,728 (EBITDA margin 0.5%).
Incorporeal Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-29-0028271).
Company details
CIN U51909PN2021PTC205424
Registration Number 205424
Incorporation Date 22 October 2021
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-29-0028271
Key People
Sharad Aannaso Patil Additional Director Sachin Bhagwant Gondhale Director Aniket Sangameshwarkar Director Recognitions & Rankings of Incorporeal Pharma
Contact details
Incorporeal Pharma Private Limited's registered office is in Sangli, Maharashtra.
- Registered AddressG3 Pranam Arcade Kacchi Bhavan Sangli, Maharashtra, India – 416416
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Incorporeal Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Incorporeal Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Incorporeal Pharma Private Limited, buy the company report.
Financials of Incorporeal Pharma Private Limited
FY 2025 filings availableIncorporeal Pharma Private Limited reported revenue of ₹98.2 Lakh (up 9% YoY) for FY 2025.
Revenue · FY 2025
₹98.2 Lakh ▲ 9%
Net profit · FY 2025
₹38,363 margin 0.4%
EBITDA · FY 2025
₹46,728 margin 0.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
EBITDA CAGR growth
1 year
▲ 89%
Revenue rose 9% in the latest year. EBITDA rose 89% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹46,728 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹38,363 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.5% | |||
| Net Profit Margin | 0.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Incorporeal Pharma Private Limited, buy the company report.
Board of directors of Incorporeal Pharma Private Limited
Incorporeal Pharma has 6 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharad Aannaso Patil | Additional Director | 21 Aug 2023 | 3 Years 2 Months | Current |
| Sachin Bhagwant Gondhale | Director | 22 Oct 2021 | 5 Years 0 Months | Current |
| Aniket Sangameshwarkar | Director | 22 Oct 2021 | 5 Years 0 Months | Current |
| Amit Ashok Shetti | Director | 22 Oct 2021 | 5 Years 0 Months | Current |
| Jayshri Rajshekhar Hiremath | Additional Director | 27 Nov 2022 | 3 Years 11 Months | Current |
| Dineshkumar Haribhau Dandekar Also directs: Amogha Bio Solutions Private Limited | Additional Director | 06 Dec 2022 | 3 Years 11 Months | Current |
Peer comparison
Incorporeal Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ropana Medicure Private Limited | ₹98.86 Lakh (FY 2025) | 146.0% | Bengaluru, Karnataka, India | |||
| Vijayam Bio Cytes Private Limited | ₹98.86 Lakh (FY 2024) | 72.0% | Chennai, Tamil Nadu, India | |||
| Albus Pharmaceuticals Private Limited | ₹98.77 Lakh (FY 2025) | -16.0% | Thrissur, Kerala, India | |||
| Ramakrishna Homeo Pharmaceuticals Private Limited | ₹98.62 Lakh (FY 2023) | 54.0% | Hyderabad, Telangana, India | |||
| BC German Pharmaceuticals Private Limited | ₹98.58 Lakh (FY 2024) | 5.0% | Patna, Bihar, India | |||
| Incorporeal Pharma Private Limitedthis company | ₹98.2 Lakh (FY 2025) | ₹38,363 | 0.4% | 9.0% | Sangli, Maharashtra, India | |
| Sakam Fine Chem Private Limited | ₹98.19 Lakh (FY 2021) | 48.0% | Hyderabad, Telangana, India | |||
| Buneesha Chem Private Limited | ₹98.12 Lakh (FY 2017) | -89.0% | Mumbai, Maharashtra, India | |||
| Rare Chemistry Private Limited | ₹98.1 Lakh (FY 2025) | -12.0% | Thane, Maharashtra, India | |||
| Beacon Pharmaceuticals Pvt Ltd | ₹98.08 Lakh (FY 2024) | 42.0% | Kolkata, West Bengal, India | |||
| Biowick Healthcare Private Limited | ₹98.08 Lakh (FY 2025) | 6439.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Incorporeal Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Incorporeal Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Incorporeal Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Incorporeal Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Incorporeal Pharma Private Limited has 6 board changes on record since 2021: 6 appointments. The latest: Sharad Aannaso Patil was appointed as Additional Director on 21 Aug 2023.
AGM
Incorporeal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Incorporeal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Sharad Aannaso Patil was appointed as Additional Director.
Appointed
Dineshkumar Haribhau Dandekar was appointed as Additional Director.
Appointed
Jayshri Rajshekhar Hiremath was appointed as Additional Director.
Appointed
Amit Ashok Shetti was appointed as Director.
Appointed
Aniket Sangameshwarkar was appointed as Director.
Appointed
Sachin Bhagwant Gondhale was appointed as Director.
Incorporation
22 Oct 2021
Incorporeal Pharma Private Limited was registered on 22 Oct 2021 with Roc Pune & aged 5 years 16 days as per MCA records.
Frequently asked questions
Incorporeal Pharma is an active private limited company based in Sangli, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 22 October 2021 (5+ years old) and is registered under CIN U51909PN2021PTC205424.
Incorporeal Pharma has 6 current directors:
- Sharad Aannaso Patil - Additional Director
- Sachin Bhagwant Gondhale - Director
- Aniket Sangameshwarkar - Director
- Amit Ashok Shetti - Director
- Jayshri Rajshekhar Hiremath - Additional Director
- Dineshkumar Haribhau Dandekar - Additional Director
The latest financial statements of Incorporeal Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Incorporeal Pharma is U51909PN2021PTC205424. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Incorporeal Pharma was incorporated on 22 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Incorporeal Pharma by revenue are Ropana Medicure Private Limited, Vijayam Bio Cytes Private Limited, Albus Pharmaceuticals Private Limited, Ramakrishna Homeo Pharmaceuticals Private Limited, BC German Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sharad Aannaso Patil was appointed as Additional Director on 21 Aug 2023. Dineshkumar Haribhau Dandekar was appointed as Additional Director on 06 Dec 2022. Jayshri Rajshekhar Hiremath was appointed as Additional Director on 27 Nov 2022. Incorporeal Pharma has 6 board changes on record in total.
Yes, Incorporeal Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-29-0028271).
The registered office of Incorporeal Pharma is at G3 Pranam Arcade Kacchi Bhavan Sangli, Maharashtra, India – 416416.
Incorporeal Pharma operates in the trading industry, in the specialty segment.
Incorporeal Pharma can be reached at its registered office: G3 Pranam Arcade Kacchi Bhavan Sangli, Maharashtra, India – 416416.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages